Table 1. Patient characteristics.
| Number of Patients (%) | ||||
|---|---|---|---|---|
| HRR-related gene mutation | Total | |||
| (+) n = 13 |
(−) n = 15 |
|||
| Sex | ||||
| Male | 7 | 8 | 15 (53.6) | |
| Female | 6 | 7 | 13 (46.4) | |
| Age, years | ||||
| Median | 61 | 64 | 64 | |
| Range | 44–81 | 39–74 | 39–81 | |
| Age ≤ 60 years | 6 | 6 | 12 (42.9) | |
| Disease status | ||||
| Locally advanced | 5 | 2 | 7 (25.0) | |
| Metastatic | 5 | 6 | 11 (39.3) | |
| Recurrence | 3 | 7 | 10 (35.7) | |
| Family history of cancer | ||||
| Yes | 8 | 9 | 17 (60.7) | |
| No | 3 | 4 | 7 (25.0) | |
| Unknown | 2 | 2 | 4 (14.3) | |
| Family history of pancreatic caner | ||||
| Yes | 1 | 3 | 4 (14.3) | |
| No | 10 | 10 | 20 (71.4) | |
| Unknown | 2 | 2 | 4 (14.3) | |
| Oxaliplatin-based chemotherapy | ||||
| Yes | 8 | 9 | 17 (60.7) | |
| No | 5 | 6 | 11 (39.3) | |